FLT3 and acute myeloid leukemia: miR-155, for example, is upregulated respect to healthy subjects having an oncogenic function in AML FLT3-ITD subgroup [91,95]; by contrast, in different AML subsets, it was demonstrated to have a tumor suppress function [106,107].